Key stats
About SPDR SERIES TRUST SPDR S&P BIOTECH ETF
Home page
Inception date
Jan 31, 2006
Structure
Open-Ended Fund
Replication method
Physical
Dividend treatment
Distributes
Distribution tax treatment
Qualified dividends
Income tax type
Capital Gains
Max ST capital gains rate
39.60%
Max LT capital gains rate
20.00%
Primary advisor
SSgA Funds Management, Inc.
Distributor
State Street Corp. (Fund Distributor)
XBI provides exposure to US biotech stocks, as defined by GICS, from a universe that invests across the market-cap spectrum. The fund equal-weights its portfolio, which in turn emphasizes small- and micro-caps and greatly reduces single-name risk. Thus, the weighted-average market-cap is much smaller than some competitors. Unlike other funds in this segment, XBI is a pure biotech play, with relatively small pharma overlap. The index is rebalanced quarterly.
Classification
Returns
| 1 month | 3 months | Year to date | 1 year | 3 years | 5 years | |
|---|---|---|---|---|---|---|
| Price performance | — | — | — | — | — | — |
| NAV total return | — | — | — | — | — | — |
What's in the fund
Exposure type
Health Technology
Stocks99.87%
Health Technology99.87%
Bonds, Cash & Other0.13%
Mutual fund0.09%
Miscellaneous0.04%
Stock breakdown by region
North America95.90%
Europe4.10%
Latin America0.00%
Asia0.00%
Africa0.00%
Middle East0.00%
Oceania0.00%
Top 10 holdings
Dividends
Dividend payout history
Assets under management (AUM)
Fund Flows
Frequently Asked Questions
XBI top holdings are Exact Sciences Corporation and Alnylam Pharmaceuticals, Inc, occupying 3.24% and 3.15% of the portfolio correspondingly.
XBI last dividends amounted to 0.11 MXN. The quarter before, the issuer paid 0.05 MXN in dividends, which shows a 48.54% increase.
XBI assets under management is 91.62 B MXN. It's fallen 10.23% over the last month.
XBI fund flows account for −31.52 B MXN (1 year). Many traders use this metric to get insight into investors' sentiment and evaluate whether it's time to buy or sell the fund.
Yes, XBI pays dividends to its holders with the dividend yield of 0.17%. The last dividend (Mar 26, 2025) amounted to 0.11 MXN. The dividends are paid quarterly.
XBI shares are issued by State Street Corp. under the brand SPDR. The ETF was launched on Jan 31, 2006, and its management style is Passive.
XBI expense ratio is 0.35% meaning you'd have to pay 0.35% of your investment to help manage the fund.
XBI follows the S&P Biotechnology Select Industry. ETFs usually track some benchmark seeking to replicate its performance and guide asset selection and objectives.
XBI invests in stocks.
XBI price has fallen by −4.66% over the last month, and its yearly performance shows a 2.44% increase. See more dynamics on XBI price chart.
NAV returns, another gauge of an ETF dynamics, have risen by −2.97% over the last month, have fallen by −2.97% over the last month, showed a −14.87% decrease in three-month performance and has increased by 3.67% in a year.
NAV returns, another gauge of an ETF dynamics, have risen by −2.97% over the last month, have fallen by −2.97% over the last month, showed a −14.87% decrease in three-month performance and has increased by 3.67% in a year.
XBI trades at a premium (2.20%) meaning the ETF is trading at a higher price than the calculated NAV.